Citadel Advisors »

Carmell Therapeutics Corp - US shares owned by Citadel Advisors

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCXW) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $15k 99k 0.15

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Carmell Therapeutics Corp - US

Antara Capital
UBS O'Connor
Balyasny Asset Management
OZ Management
Periscope Capital
Millennium Management
Highbridge Capital Management
Exos TFP Holdings
Exos Asset Management
Citadel Advisors
CNH Partners
Walleye Trading Advisors
Cowen And Company
Saba Capital Management
Whitebox Advisors

View all funds holding Carmell Therapeutics Corp - US